A Decade of Robotic Liver Resection: Study Highlights Perioperative and Survival Outcomes

A team of AdventHealth urologists was recognized at ERUS26 for its work helping establish pathways for transcontinental telesurgery.

A new study from AdventHealth physicians published in Gastrointestinal Endoscopy examines the use of antibiotic prophylaxis before peroral cholangioscopy.

AdventHealth Translational Research Institute (TRI) researcher Dr. Cheehoon Ahn explores potential benefits of exercise within adipose (fat) tissue.

What happens when care for pediatric and adult patients with Down syndrome is connected in one place?

AdventHealth is participating in the INNOVATE trial, a Phase 3, multi-center study comparing the investigational BrioVAD system to the HeartMate 3 LVAD.

CAR-T therapies have emerged as new treatment options for certain types of cancer through a one-time infusion that can lead to long-lasting remission.

Afflicting 30-50% of patients with late-life depression, apathy is a challenging psychiatric syndrome in older adulthood that can result in lack of motivation leading to poor self-care, physical...

In June 2025, AdventHealth Abdominal Transplant Surgeon and Surgical Oncologist Ryan Day, MD, worked with a multidisciplinary team to perform Central Florida’s first liver transplant for unresectable...

GammaTile is the first and only tile-based radiation therapy for the treatment of
operable brain tumors. The AdventHealth Neuroscience Institute began performing GammaTile procedures in 2021 and was...

Using a muscle lab-on-chip model aboard the International Space Station (ISS), AdventHealth Translational Research Institute’s Dr. Paul Coen has been working with a multidisciplinary team from the...

While most clinical trials for Alzheimer’s disease have focused on patients with early or mild cognitive impairment, roughly 30% of those with Alzheimer’s have moderate stage disease for which there...

Under the leadership of Scientific Director and Principal Investigator Bret H. Goodpaster, PhD, the AdventHealth Translational Research Institute (TRI) is now enrolling men and women 70 years of age...